Difference between revisions of "PCD PIV Current Issues Discussion"
(New page: == '''Current Issues related to Infusion Pumps''' == When PIV is used with DEC to support the reporting of the status of a infusion, the order ID (Placer Order Number) provided in ORC-2 ...) |
|||
| Line 1: | Line 1: | ||
| + | [[Category:PCD]] [[Category:PCD PIV]] | ||
| + | |||
| + | |||
== '''Current Issues related to Infusion Pumps''' == | == '''Current Issues related to Infusion Pumps''' == | ||
| + | The following issues are to be discussed at an upcoming F2F meeting of the pump vendors: | ||
| − | When PIV is used with DEC to support the reporting of the status of a infusion, the order ID (Placer Order Number) provided in ORC-2 (PCD-03 transaction) should be contained in the PCD-01 message | + | 1. When PIV is used with DEC to support the reporting of the status of a infusion, the order ID (Placer Order Number) provided in ORC-2 (PCD-03 transaction) should be contained in the PCD-01 message |
- Currently PCD-01 allows for a single Placer Order Number in a message; however, an infuser may have different infusions programmed and/or running at the same time on a single channel. We need to support Placer Order Numbers in a PCD-01 message. | - Currently PCD-01 allows for a single Placer Order Number in a message; however, an infuser may have different infusions programmed and/or running at the same time on a single channel. We need to support Placer Order Numbers in a PCD-01 message. | ||
| + | 2. Revisit pump model to account for running channel | ||
| − | + | 3. Revisit pump model to account for events (e.g. piggyback completed) | |
| − | |||
| − | |||
| − | Revisit pump model to account for events (e.g. piggyback completed) | ||
| + | 4. PCD-03: RXG-17 and 18 (Give Strength and Units) and RXG-23 and 24 (Give Drug Strength Volume and Units) are used to determine the concentration of the drug as defined in the pump drug library. Since not all drugs are defined with a concentration, these fields should be conditional instead of RE. We need to define the condition. | ||
| − | |||
| + | ==='''PIV Trial Implementation Version 1.2'''=== | ||
| − | + | The following should be considered for Trial Implementation v1.2: | |
- Develop new Change Proposal based on outcome of the issues above. | - Develop new Change Proposal based on outcome of the issues above. | ||
Revision as of 09:43, 15 April 2009
The following issues are to be discussed at an upcoming F2F meeting of the pump vendors:
1. When PIV is used with DEC to support the reporting of the status of a infusion, the order ID (Placer Order Number) provided in ORC-2 (PCD-03 transaction) should be contained in the PCD-01 message - Currently PCD-01 allows for a single Placer Order Number in a message; however, an infuser may have different infusions programmed and/or running at the same time on a single channel. We need to support Placer Order Numbers in a PCD-01 message.
2. Revisit pump model to account for running channel
3. Revisit pump model to account for events (e.g. piggyback completed)
4. PCD-03: RXG-17 and 18 (Give Strength and Units) and RXG-23 and 24 (Give Drug Strength Volume and Units) are used to determine the concentration of the drug as defined in the pump drug library. Since not all drugs are defined with a concentration, these fields should be conditional instead of RE. We need to define the condition.
PIV Trial Implementation Version 1.2
The following should be considered for Trial Implementation v1.2:
- Develop new Change Proposal based on outcome of the issues above.
- Include Change Proposal for PIV (from Jan 2009) regarding the use of MDC and UCUM encodings for units.
- Change Proposal for Trial Implementation Version 1.0 that resulted in v 1.1 was approved by the TC but should be submitted for public comment.